| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99337 |
|
1,731 |
859 |
$22K |
| 99350 |
Prolong home eval add 15m |
985 |
808 |
$12K |
| 99491 |
Ccm add 20min |
1,245 |
1,240 |
$2K |
| 87428 |
|
65 |
64 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
27 |
26 |
$600.00 |
| 99497 |
|
498 |
431 |
$582.99 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
105 |
104 |
$375.36 |
| 86769 |
|
40 |
40 |
$337.04 |
| 86328 |
|
20 |
20 |
$271.38 |
| 99490 |
Ccm add 20min |
270 |
270 |
$215.10 |
| G0181 |
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans |
146 |
146 |
$207.87 |
| 99349 |
|
45 |
43 |
$87.07 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
15 |
$71.88 |
| 90686 |
|
20 |
16 |
$17.93 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
56 |
56 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
38 |
37 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
36 |
36 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
15 |
15 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
18 |
15 |
$0.00 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
26 |
23 |
$0.00 |
| 99072 |
|
25 |
24 |
$0.00 |